π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc i...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-01
Trial ID
NCT01756521
Treatments Being Tested
Traditional management of community-acquired pneumonia (CAP) relies on the ...
Status
Completed
Location
4th Department of Internal Medicine, Attikon University Hospital
Start Date
2021-01-25
Trial ID
NCT04724044
Treatments Being Tested
The purpose of this study is to demonstrate a lack of effect of venlafaxine...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-12
Trial ID
NCT02637193
Treatments Being Tested
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
A single-center, randomized, double-blinded, 2-way crossover, placebo-contr...
Status
Unknown
Location
Peking University Third Hospital Drug Clinical Trial Center
Start Date
2012-07
Trial ID
NCT01653990
Treatments Being Tested
Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01297062
Treatments Being Tested
* Determine whether VI-0521 has an effect on the electrical activity of the...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-02
Trial ID
NCT00839891
Treatments Being Tested
This is a Phase 1, double-blind, randomized, repeat-dose, single -dite, 4-a...
Status
Completed
Location
Research Site 1
Start Date
2008-05
Trial ID
NCT00675701
Treatments Being Tested
The purpose of this study is to evaluate the effect of povorcitinib on the ...
Status
Completed
Location
Celerion Clinical Research Unit
Start Date
2024-07-12
Trial ID
NCT06441318
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested